Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Deals

The NewCo boom signals China’s galloping speed of innovation

Companies founded in the West with Asian assets tell a story of China speed

January 29, 2025 2:23 AM UTC

If anyone still doubts the competitiveness of China biotechs in innovation and dealmaking, the boom of companies founded on the so-called NewCo Model should settle that question.

The significance is not only for the pace of new company creation but for the assets on which they are based, touching on the hottest areas of innovation, such as immune cell reset and next-generation obesity therapies, where biotechs and pharmas are racing to be best if not first. ...

Get Unlimited Access
To view this item, login or register for a free account.
Or Purchase This Article